This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soininen, A.
Right arrow Articles by Käyhty, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soininen, A.
Right arrow Articles by Käyhty, H.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 2000, p. 468-476, Vol. 7, No. 3
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Are the Enzyme Immunoassays for Antibodies to Pneumococcal Capsular Polysaccharides Serotype Specific?

Anu Soininen,1,* Germie van den Dobbelsteen,2 Lukas Oomen,2 and Helena Käyhty1

Department of Vaccines, National Public Health Institute (KTL), Helsinki, Finland,1 and Laboratory for Vaccine Research, National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands2

Received 5 November 1999/Returned for modification 7 January 2000/Accepted 9 March 2000

The specificity of antibody binding to pneumococcal capsular polysaccharides (Pnc PSs) measured by enzyme immunoassay (EIA) was studied by inhibition of antibody binding by homologous and heterologous PSs. We found extensive cross-reactivity of antibody binding to type 6B, 19F, and 23F PSs but not to type 14 PS, even after treatment with cell wall PS (CPS). The cross-reactive antibody was highly prevalent in sera of infants and adults with naturally acquired antibody, but not in sera of infants and adults immunized with pneumococcal vaccines. However, a type 11A antibody response was seen after vaccination with heterologous PSs. Monoclonal antibodies prepared against a type 6B PS-tetanus toxoid conjugate recognized also other than the specific type of PS in the EIA, implying the possible existence of a cross-reactive epitope. Remarkable differences in specificity among type 6B PS preparations from different manufacturers were found. Moreover, different lots of type 11A PS from the same manufacturer showed differences in specificity. The results suggest that some Pnc PS preparations may contain cross-reactive epitopes or impurities, other than CPS, that are common to many types of Pnc PS. The specificity of antibodies, especially in sera from nonimmunized subjects, measured by EIA can be questioned.


* Corresponding author. Mailing address: Laboratory of Vaccine Immunology, Department of Vaccines, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland. Phone: 358 9 4744 8588. Fax: 358 9 4744 8599. E-mail: anu.soininen{at}ktl.fi.


Clinical and Diagnostic Laboratory Immunology, May 2000, p. 468-476, Vol. 7, No. 3
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Rose, M. A., Schubert, R., Strnad, N., Zielen, S. (2005). Priming of Immunological Memory by Pneumococcal Conjugate Vaccine in Children Unresponsive to 23-Valent Polysaccharide Pneumococcal Vaccine. CVI 12: 1216-1222 [Abstract] [Full Text]  
  • Inostroza, J., Villanueva, S., Mason, K., Leiva, L. E., Sorensen, R. U. (2005). Effects of Absorption with Pneumococcal Type 22F Polysaccharide on Maternal, Cord Blood, and Infant Immunoglobulin G Antipneumococcal Polysaccharide Antibodies. CVI 12: 722-726 [Abstract] [Full Text]  
  • Sikkema, D. J., Ziembiec, N. A., Jones, T. R., Hildreth, S. W., Madore, D. V., Quataert, S. A. (2005). Assignment of Weight-Based Immunoglobulin G1 (IgG1) and IgG2 Units in Antipneumococcal Reference Serum Lot 89-S(F) for Pneumococcal Polysaccharide Serotypes 1, 4, 5, 7F, 9V, and 18C. CVI 12: 218-223 [Abstract] [Full Text]  
  • Feikin, D. R., Elie, C. M., Goetz, M. B., Lennox, J. L., Carlone, G. M., Romero-Steiner, S., Holder, P. F., O'Brien, W. A., Whitney, C. G., Butler, J. C., Breiman, R. F. (2004). Specificity of the Antibody Response to the Pneumococcal Polysaccharide and Conjugate Vaccines in Human Immunodeficiency Virus-Infected Adults. CVI 11: 137-141 [Abstract] [Full Text]  
  • Biagini, R. E., Schlottmann, S. A., Sammons, D. L., Smith, J. P., Snawder, J. C., Striley, C. A. F., MacKenzie, B. A., Weissman, D. N. (2003). Method for Simultaneous Measurement of Antibodies to 23 Pneumococcal Capsular Polysaccharides. CVI 10: 744-750 [Abstract] [Full Text]  
  • Artz, A. S., Ershler, W. B., Longo, D. L. (2003). Pneumococcal Vaccination and Revaccination of Older Adults. Clin. Microbiol. Rev. 16: 308-318 [Abstract] [Full Text]  
  • Soininen, A., Karpala, M., Wahlman, S.-L., Lehtonen, H., Kayhty, H. (2002). Specificities and Opsonophagocytic Activities of Antibodies to Pneumococcal Capsular Polysaccharides in Sera of Unimmunized Young Children. CVI 9: 1032-1038 [Abstract] [Full Text]  
  • Jansen, W. T. M., Vakevainen-Anttila, M., Kayhty, H., Nahm, M., Bakker, N., Verhoef, J., Snippe, H., Verheul, A. F. M. (2001). Comparison of a Classical Phagocytosis Assay and a Flow Cytometry Assay for Assessment of the Phagocytic Capacity of Sera from Adults Vaccinated with a Pneumococcal Conjugate Vaccine. CVI 8: 245-250 [Abstract] [Full Text]  
  • Concepcion, N. F., Frasch, C. E. (2001). Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent Assay. CVI 8: 266-272 [Abstract] [Full Text]  
  • Jansen, W. T. M., Hogenboom, S., Thijssen, M. J. L., Kamerling, J. P., Vliegenthart, J. F. G., Verhoef, J., Snippe, H., Verheul, A. F. M. (2001). Synthetic 6B Di-, Tri-, and Tetrasaccharide-Protein Conjugates Contain Pneumococcal Type 6A and 6B Common and 6B- Specific Epitopes That Elicit Protective Antibodies in Mice. Infect. Immun. 69: 787-793 [Abstract] [Full Text]